Resource library

OTC Topical Resources

OTC topical resources for released components, approved masters, phase additions, bulk-to-fill genealogy, testing, label reconciliation and human quality review.

Guides: 4 guides
Glossary: 3 glossary entries
Checklist: 9 buyer questions

Reference & Scope

This FDA overview explains the US OTC monograph route, not whether your topical product meets it. Intended use and market distinguish drugs from cosmetics; your regulatory team determines the applicable order or application.

Production & Quality Records

Pathway status does not make a batch acceptable. These readings follow bulk-to-fill records, master versus executed instructions, labeling reconciliation and the quality unit's review; your approved procedures set the limits.

Software Pages

Compare the production workflow and laboratory information with your own records, responsibilities and system boundaries.

Evaluate the software

Work through these questions with your production and quality teams, then use them to plan an evaluation with your own records.

Product and market classificationWhich products are drugs, cosmetics or both, which markets are in scope, and who documents the applicable order or application?

Released Components Before DispensingWhat identity, testing and supplier evidence must our quality team review before recording permission to use each component lot?

Component Evidence Before Use

Approved Master and Actual BatchCan we identify the assigned master revision and reconstruct actual component lots, quantities and signed execution records for one batch?

Approved Instructions and Actual Execution

Phase additions and mixing evidenceWhich additions, mixing times, temperatures and in-process checks do our approved procedures define, and how are exceptions recorded for review?

Bulk-to-Fill GenealogyCan we trace a bulk lot through holding, splits and filling runs to every finished tube or jar lot?

Fill and Label ReconciliationHow will our team reconcile fill checks and issued, used, returned and destroyed packaging and labels against the approved revisions?

Required Tests and Stability EvidenceWhich tests and stability records apply to our product, and how will pending evidence remain distinguishable from reviewed results without inventing a universal testing cycle?

Human Quality and Customer ResponsibilitiesWho reviews deviations and records the quality decision, and is any separate contract-customer review responsibility recorded as agreed?

Configuration and System HandoversWhich systems own masters, laboratory data and inventory status, and who supplies configuration, reconciliation and intended-use testing evidence?

The existing production guide remains email-gated. Review its product, market and system scope with your responsible team; printing is available in the reader. Open the existing guide offer.

Explore the workflow

The illustrated five-step workflow follows component testing and acceptance, dispensing to the master record, phase additions, filling and label reconciliation, and a quality unit reviewing the batch.

Explore the otc topicals workflow